Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2011

Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470(7333):214-20.

Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnström J, Sevvana M, et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011;108(23):9613-8.

Bretz J, Garcia J, Huang X, Kang L, Zhang Y, Toellner K-, et al. Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors. Blood. 2011;117(7):2179-88.

Nassar A, Cohen C, Agersborg SS, Zhou W, Lynch KA, Albitar M, et al. Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens. Arch Pathol Lab Med. 2011;135(7):896-902.

Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin P-, et al. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 2011;21(1):56-67.

Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 2011;305(2):163-74.

Calloway N, Owens T, Corwith K, Rodgers W, Holowka D, Baird B. Stimulated association of STIM1 and Orai1 is regulated by the balance of PtdIns(4,5)P₂ between distinct membrane pools. J Cell Sci. 2011;124(Pt 15):2602-10.

Ross AE, Emadi A, Marchionni L, Hurley PJ, Simons BW, Schaeffer EM, et al. Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity. BJU Int. 2011;108(3):447-54.

Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng F-, et al. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol. 2011;22(6):1041-52.

Rand JH. Home free? Not after 3! Blood. 2011;118(17):4504-6.